BOSTON — Atul Gawande’s new Boston-based health care venture has yet to design any products, but it could be changing the way some employees of Amazon, Berkshire Hathaway, and JPMorgan Chase receive their health care within the year, the venture’s chief operating officer told a federal judge on Thursday.

The venture’s COO, Jack Stoddard, testified for an hour on Thursday at a Boston federal courthouse during a contentious, technical, and unusually long hearing. The hearing was intended to determine the fate of David Smith, a former midlevel executive at Optum. Smith began a new job at Gawande’s venture, referred to in court documents as ABC, earlier in January. Optum is suing to prevent Smith from continuing to work for the new company.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy